Toronto Dominion Bank’s BeOne Medicines Ltd ONC Stock Holding History

Toronto Dominion Bank’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-333	Closed	-$52.1K	–	1540
2024 Q1	$52.1K	Hold	333	–	–	﹤0.01%	1085
2023 Q4	$60.1K	Hold	333	–	–	﹤0.01%	1194
2023 Q3	$59.9K	Buy	333 +208	+166%	+$41.2K	﹤0.01%	1201
2023 Q2	$22K	Hold	125	–	–	﹤0.01%	1261
2023 Q1	$27K	Buy	+125	New	+$30K	﹤0.01%	1254
2020 Q4	–	Sell	-4,153	Closed	-$1.19M	–	1454
2020 Q3	$1.19M	Buy	4,153 +2,453	+144%	+$577K	﹤0.01%	818
2020 Q2	$320K	Hold	1,700	–	–	﹤0.01%	954
2020 Q1	$209K	Hold	1,700	–	–	﹤0.01%	951
2019 Q4	$282K	Hold	1,700	–	–	﹤0.01%	984
2019 Q3	$208K	Hold	1,700	–	–	﹤0.01%	1110
2019 Q2	$211K	Hold	1,700	–	–	﹤0.01%	1115
2019 Q1	$224K	Sell	1,700 -900	-35%	-$121K	﹤0.01%	1162
2018 Q4	$365K	Buy	+2,600	New	+$345K	﹤0.01%	1049
2018 Q2	–	Sell	-31	Closed	-$5K	–	1585
2018 Q1	$5K	Buy	+31	New	+$4.2K	﹤0.01%	1213

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Toronto Dominion Bank's ONC Position: Q2 2024 in Review

Toronto Dominion Bank sold out of BeOne Medicines Ltd (ONC) in Q2 2024, closing a stake of 333 shares — an estimated $52.1K sold.

Toronto Dominion Bank first reported a position in ONC in Q1 2018 and held it in 14 quarters. The position peaked at $1.19M in Q3 2020. 200 funds tracked by Wall St. Rank hold ONC as of Q2 2024.

Toronto Dominion Bank reported no remaining BeOne Medicines Ltd position as of Q2 2024 after selling out during the quarter.
Toronto Dominion Bank sold 333 BeOne Medicines Ltd shares in Q2 2024, an estimated $52.1K.
Toronto Dominion Bank first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 14 quarters.
Toronto Dominion Bank's BeOne Medicines Ltd position peaked at $1.19M in Q3 2020.
200 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2024.

Based on Toronto Dominion Bank's 13F filing for Q2 2024, filed 14 Aug 2024.